Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, July 1, 2025.
CRISPR Therapeutics AG - Common Shares (NASDAQ:CRSP)
Long-Term Uptrend (+90) - CRSP is in a strong uptrend that is likely to continue. While CRSP is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid CRSP?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRSP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRSP
The long-term trend has been UP since Jun 18th, 2025 at 46.0699
The intermediate-term trend has been UP since May 20th, 2025 at 39.3999
The short-term trend has been UP since Jun 17th, 2025 at 42.3500
Smart Scan Analysis for CRSP
Based on our trend formula, CRSP is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 48.22 | 49.92 | 46.60 | 48.50 | -0.14 |
| Prev. Close | Volume | Bid | Ask | Time |
| 48.64 | 3235899 | 2025-07-01 15:59:55 |
| Year High | 73.9 | Year High Date | 2018-05-24 |
| Year Low | 23.01 | Year Low Date | 2018-01-03 |
| 52wk High | 63.68 | 52wk High Date | 2024-07-16 |
| 52wk Low | 30.04 | 52wk Low Date | 2025-04-07 |
| Average Volume | 3,483,361 | Shares Outstanding | 86,364 |
| Market Cap | 2,616M | Assets | 216,610,200M |
| Liabilities | 336,942,000M | P/E Ratio | -8.27030000 |
| Volatility | 74.22 |